WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005068461) STEREOISOMERIC COMPOUNDS AND METHODS FOR THE TREATMENT OF GASTROINTESTINAL AND CENTRAL NERVOUS SYSTEM DISORDERS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/068461    International Application No.:    PCT/US2005/000510
Publication Date: 28.07.2005 International Filing Date: 07.01.2005
IPC:
C07D 453/02 (2006.01)
Applicants: ARYX THERAPEUTICS [US/US]; 2255 Martin Avenue, Suite F, Santa Clara, CA 95050 (US) (For All Designated States Except US).
IRWIN, Ian [US/US]; (US) (For US Only).
PALME, Monica [US/US]; (US) (For US Only).
BECKER, Cyrus [US/US]; (US) (For US Only)
Inventors: IRWIN, Ian; (US).
PALME, Monica; (US).
BECKER, Cyrus; (US)
Agent: CRAWFORD, Bradley, W.; McDonnell Boehnen Hulbert & Berghoff LLP, 300 South Wacker Drive, Suite 3100, Chicago, IL 60606 (US)
Priority Data:
60/534,892 07.01.2004 US
60/560,938 09.04.2004 US
Title (EN) STEREOISOMERIC COMPOUNDS AND METHODS FOR THE TREATMENT OF GASTROINTESTINAL AND CENTRAL NERVOUS SYSTEM DISORDERS
(FR) COMPOSES STEREO-ISOMERES ET METHODES DE TRAITEMENT DE TROUBLES GASTRO-INTESTINAUX ET DU SYSTEME NERVEUX CENTRAL
Abstract: front page image
(EN)The subject invention provides stereoisomeric compounds of formula (X): wherein the variables are as defined herein, and compositions for the safe and effective treatment of various gastrointestinal disorders including, but not limited to, gastroparesis, gastroesophageal reflux and related conditions. The compounds of the subject invention are also useful in treating a variety of conditions involving the central nervous system.
(FR)L'invention concerne des composés stéréo-isomères de formule (X), dans laquelle les variables sont telles que définies ci-après, et des compositions destinées au traitement fiable et efficace de divers troubles gastro-intestinaux comprenant, notamment mais non exclusivement, la gastroparésie, le reflux gastro-oesophagien et des troubles liés. Les composés de cette invention sont utilisés dans le traitement de divers troubles impliquant le système nerveux central.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)